PETMED EXPRESS INC

PETS

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
PETS
CIK0001040130
SIC5912
SectorRetail Trade
Industry CategoryRetail
Industry GroupRetail – Drug & Proprietary Stores

Contact

Address420 SOUTH CONGRESS AVENUE, DELRAY BEACH, FL, 33445
Website 1800petmeds.com
Phone(561) 426-4444
CEOMatthew N. Hulett
Employees210

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$247.01 million
Pre-Tax Income$1.92 million
Net Income$357,000.00
Net Income to Common$357,000.00
EPS$0.02
View All
Balance Sheet
Cash$50.10 million
Assets$144.80 million
Liabilities$48.61 million
Common Equity$96.18 million
Liabilities & Equity$144.80 million
View All
Cash Flow Statement
Calculations
NOPAT$122,107.00
EBITDA$8.44 million
Price to Earnings$185.73
Price to Book$0.69
ROE0.36%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Fusemachines Appoints Christine Chambers, Experienced Public Company CFO, as Chief Financial Officer

New Role to Strengthen Financial Leadership and Drive Scalable Growth Through Operational AlignmentNEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fusemachines, Inc. (“Fusemachines” or the “Company”), a leading provider of enterprise AI products and services, today announced the appointment of Christine Chambers as the Company’s new Chief Financial Officer (“CFO”). In her new role, Christine will play a crucial part in aligning the Company’s financial structure with its long-term vision and goal of

Article Link

Etsy (ETSY) Q2 Earnings Miss Estimates

Etsy (ETSY) delivered earnings and revenue surprises of -53.70% and +3.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Article Link

Spotlight On Promising Penny Stocks In July 2025

As the U.S. stock market continues to reach new highs, with the S&P 500 and Nasdaq setting records, investors are keenly observing opportunities beyond the major indices. For those willing to explore outside of well-known names, penny stocks—often representing smaller or newer companies—remain a relevant investment area despite their somewhat outdated label. This article will spotlight three penny stocks that exhibit financial strength and potential for growth, offering intriguing...

Article Link

PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills

PetMeds and myBalto Host “Top of the Class” Drive to Provide Care for Pets Who Need It MostDELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS) today announced that it partnered with the myBalto Foundation for its recent “Top of the Class” fundraising drive, resulting in nearly $45,000 in donations. myBalto is a leading platform dedicated to empowering veterinary hospitals to support pets with critical veterinary care. Its Foundation offers veter

Article Link

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS) received on July 2, 2025, an expected notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “Form 10-K”), with the Securities and Exchange Commission (“SEC”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), wh

Article Link